Bristol Myers stock takes a hit from earnings miss and lower outlook amid disappointing Revlimid sales

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Shares of Bristol Myers Squibb Co. shed 2.2% in premarket trading Thursday, after the drugmaker missed second-quarter earnings expectations and cut its...

Shares of Bristol Myers Squibb Co. BMY shed 2.2% in premarket trading Thursday, after the drugmaker missed second-quarter earnings expectations and cut its full-year outlook, amid a more rapid than expected decline in sales of its cancer treatment Revlimid. Net income rose to $2.07 billion, or 99 cents a share, from $1.42 billion, or 66 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $1.75 missed the FactSet consensus of $1.98. Revenue fell 5.

2% in premarket trading Thursday, after the drugmaker missed second-quarter earnings expectations and cut its full-year outlook, amid a more rapid than expected decline in sales of its cancer treatment Revlimid. Net income rose to $2.07 billion, or 99 cents a share, from $1.42 billion, or 66 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $1.75 missed the FactSet consensus of $1.98. Revenue fell 5.6% to $11.

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alphabet stock jumps on earnings while Microsoft shares dip, and other stocks on the moveAlphabet, Microsoft, Dish Networks and PacWest Bancorp are among the stocks in the spotlight.
Source: MarketWatch - 🏆 3. / 97 Read more »

LVMH knocks European shares lower after six-day winning runEuropean shares are set to snap a six-day winning run on Wednesday, hurt by underwhelming results from French luxury goods giant LVMH as well as nerves ahead of the Federal Reserve's interest rate decision later in the day.
Source: Reuters - 🏆 2. / 97 Read more »

Unilever quarterly sales beat estimates, boost sharesUnilever on Tuesday beat underlying sales growth forecasts after again raising prices to offset higher costs, boosting shares in the maker of Dove soap and Ben & Jerry's ice cream.
Source: Reuters - 🏆 2. / 97 Read more »

ESPN soccer analyst Shaka Hislop shares video message after collapsing on-airDuring ESPN's on-site pregame coverage of Sunday's Real Madrid-AC Milan friendly, Hislop began teetering back and forth while host Dan Thomas was talking.
Source: NBCLA - 🏆 319. / 59 Read more »

David Byrne on New Tech and AI | Gizmodo InterviewTalking Heads singer shares his thoughts about emerging new tech from AI to VR.
Source: Gizmodo - 🏆 556. / 51 Read more »